产品

您的位置:首页 > 食品资讯 > 外讯导读 > 欧盟评估转基因里氏木霉菌株RF6197生产的内切多聚半乳糖醛酸酶的安全性

欧盟评估转基因里氏木霉菌株RF6197生产的内切多聚半乳糖醛酸酶的安全性

来源:好招商食品网 外讯导读   |  2024-04-25
   好招商食品网讯 2023年6月29日,欧盟食品安全局就一种内切多聚半乳糖醛酸酶(endo-polygalacturonase)的安全性评价发布意见。
 
  据了解,这种食品酶是由转基因里氏木霉菌株RF6197生产的,旨在用于果汁生产中的水果和蔬菜加工、果汁以外产品的水果和蔬菜加工、葡萄酒和葡萄酒醋的生产、咖啡脱脂以及作为调味制剂的植物提取物的生产。
 
  经过评估,专家小组认为,在预期的使用条件下,不能排除饮食暴露引起过敏反应的风险,尤其是对花粉过敏的个体。根据所提供的数据,评估小组得出结论,这种食品酶在预期使用条件下不会引起安全问题。部分原文报道如下:
 
  The food enzyme endo-polygalacturonase ((1–4)-α-d-galacturonan glycanohydrolase; EC 3.2.1.15) is produced with the genetically modified Trichoderma reesei strain RF6197 by AB Enzymes GmbH. The genetic modifications do not give rise to safety concerns. The food enzyme was considered free from viable cells of the production organism and its DNA. It is intended to be used in five food manufacturing processes: fruit and vegetable processing for juice production, fruit and vegetable processing for products other than juices, production of wine and wine vinegar, coffee demucilation and production of plant extracts as flavouring preparations. Since residual amounts of the total organic solids (TOS) are removed during the coffee demucilation and the production of flavouring extracts, dietary exposure was calculated only for the remaining three food processes. It was estimated to be up to 0.156 mg TOS/kg body weight (bw) per day in European populations. Genotoxicity tests did not indicate a safety concern. The systemic toxicity was assessed by means of a repeated dose 90-day oral toxicity study in rats. The Panel identified a no observed adverse effect level of 1,000 mg TOS/kg bw per day, the highest dose tested, which, when compared with the estimated dietary exposure, resulted in a margin of exposure of at least 6,410. A search for the similarity of the amino acid sequence of the food enzyme to known allergens was made and matches were found with a number of pollen allergens. The Panel considered that, under the intended conditions of use, the risk of allergic reactions by dietary exposure, particularly in individuals sensitised to pollen cannot be excluded. based on the data provided, the Panel concluded that this food enzyme does not give rise to safety concerns under the intended conditions of use.
 

TAGS:安全局 转基因 霉菌 食品安全 欧盟
免责声明:本站部分文章转载自网络,图文仅供行业学习交流使用,不做任何商业用途。文章仅代表原作者个人观点,其原创性及文章内容中图文的真实性、完整性等未经本站核实,仅供读者参考。
上一篇: 欧盟评估非转基因副地衣芽孢杆菌菌株LMGS-30155生产的枯草杆菌蛋白酶的安全性
下一篇: 欧盟评估转基因里氏木霉菌株RF6201生产的果胶酯酶的安全性